Emergent BioSolutions Inc.
EBS
$9.12
-$0.115-1.25%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -36.59% | 14.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -36.59% | 14.12% | |||
| Cost of Revenue | -21.98% | 76.63% | |||
| Gross Profit | -49.16% | -12.53% | |||
| SG&A Expenses | -16.51% | -13.18% | |||
| Depreciation & Amortization | -0.61% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.28% | -13.67% | |||
| Operating Income | -99.01% | 1,272.09% | |||
| Income Before Tax | -118.12% | 435.87% | |||
| Income Tax Expenses | -119.43% | 567.57% | |||
| Earnings from Continuing Operations | -117.65% | 317.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -117.65% | 317.25% | |||
| EBIT | -99.01% | 1,272.09% | |||
| EBITDA | -68.75% | 258.10% | |||
| EPS Basic | -117.71% | 316.45% | |||
| Normalized Basic EPS | -118.43% | 545.58% | |||
| EPS Diluted | -118.61% | 305.28% | |||
| Normalized Diluted EPS | -119.41% | 523.03% | |||
| Average Basic Shares Outstanding | -0.37% | 0.37% | |||
| Average Diluted Shares Outstanding | -5.41% | 5.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||